PTTG1 promotes migration and invasion of human non-small cell lung cancer cells and is modulated by miR-186-Reference-Cited by-全球学者库

PTTG1 promotes migration and invasion of human non-small cell lung cancer cells and is modulated by miR-186

Published:2013-05-13 Issue:9 Volume:34 Page:2145-2155
ISSN:1460-2180
Container-title:Carcinogenesis
language:en
Short-container-title:

Author:

Li Hongli,Yin Chonggao,Zhang Baogang,Sun Yonghong,Shi Lihong,Liu Ningbo,Liang Shujuan,Lu Shijun,Liu Yuqing,Zhang Jin,Li Fengjie,Li Wentong,Liu Fei,Sun Lei,Qi Yuliang

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/article-pdf/34/9/2145/17293808/bgt158.pdf

Reference37 articles.

1. Global cancer statistics;Jemal;CA. Cancer J. Clin,2011

2. Suppression of lung cancer with siRNA targeting PTTG;Kakar;Int. J. Oncol,2006

3. Roles of the PI-3K and MEK pathways in Ras-mediated chemoresistance in breast cancer cells;Jin;Br. J. Cancer,2003

4. Isolation and characterization of a pituitary tumor-transforming gene (PTTG);Pei;Mol. Endocrinol,1997

5. Structure, expression, and function of human pituitary tumor-transforming gene (PTTG);Zhang;Mol. Endocrinol,1999

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clonal variability in chromosomal instability as a potential driver in the acquisition of tumorigenic phenotype in chronic arsenic-exposed and hsa-miR-186 overexpressing human keratinocytes;Toxicology and Applied Pharmacology;2023-11

2. Chromosome 5;Cancer Genes;2023-07-09

3. Molecular characterization based on tumor microenvironment-related signatures for guiding immunotherapy and therapeutic resistance in lung adenocarcinoma;Frontiers in Pharmacology;2023-01-16

4. Clinical significance of securin expression in solid cancers: A PRISMA-compliant meta-analysis of published studies and bioinformatics analysis based on TCGA dataset;Medicine;2022-09-16

5. LncRNA-AC009948.5 promotes invasion and metastasis of lung adenocarcinoma by binding to miR-186-5p;Frontiers in Oncology;2022-08-19